Retinalamin Research for Diabetic Retinopathy
An evidence-based overview of research examining Retinalamin in the context of diabetic retinopathy. This page synthesizes findings from peer-reviewed literature.
Research Summary
Russian clinical experience includes retinalamin use for diabetic retinopathy, particularly non-proliferative stages. Studies report improvements in visual acuity and ERG parameters. Combined with standard diabetic management in clinical protocols. No Western validation studies exist.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Diabetic Retinopathy
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Retinalamin may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.